AIM2 and hepatocellular carcinoma: Previous study revealed that AIM2 inflammasome in HCC cells suppressed mammalian target of rapamycin (mTOR)‐S6K1 pathway,28 and suggested that mTOR pathway might be involved in AIM2‐induced downstream pathway.